The HLA - Narcolepsy DRB1*15 DQB1*0602 DQA1*0102 Test is a specialized diagnostic assessment aimed at identifying specific human leukocyte antigen (HLA) markers that are strongly associated with narcolepsy, a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden sleep attacks. This test focuses on detecting the presence of the HLA-DRB1*15, HLA-DQB1*0602, and HLA-DQA1*0102 alleles, which have been linked to an increased susceptibility to narcolepsy, particularly Type 1 narcolepsy that involves cataplexy (a sudden, temporary loss of muscle tone triggered by strong emotions).
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, this test provides critical insights into an individual's genetic predisposition to narcolepsy, facilitating early detection and the potential for targeted management strategies. The cost of the test is 1450 AED, reflecting the sophisticated technology and expertise required to accurately identify these specific genetic markers. By undergoing this test, individuals who exhibit symptoms of narcolepsy or have a family history of the disorder can gain a clearer understanding of their condition, enabling them to seek appropriate treatment and lifestyle adjustments to manage their symptoms effectively.
The Immune Deficiency Panel 1 Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at evaluating the body's immune system functionality. This test is particularly designed to detect any deficiencies or disorders within the immune system that might make an individual more susceptible to infections, autoimmune diseases, or other immune-related conditions. With a cost of 1450 AED, the test encompasses a comprehensive analysis of various components of the immune system, including but not limited to, the assessment of specific antibodies, immune cell counts, and the functionality of immune responses.
DNA Labs UAE, a leading laboratory in the region, conducts this test with precision and care, ensuring accurate and reliable results. The test is recommended for individuals experiencing frequent infections, unexplained health issues, or those with a family history of immune disorders. It provides crucial insights into the immune system's health, guiding healthcare professionals in devising appropriate treatment plans or preventive measures. The Immune Deficiency Panel 1 Test is a vital tool in understanding and managing immune system-related disorders, contributing to better health outcomes and quality of life.
The Immunotyping Serum Test, available at DNA Labs UAE, is a sophisticated diagnostic procedure priced at 1450 AED. This test is designed to analyze the immune system's characteristics by examining the proteins, or immunoglobulins, present in the blood serum. It is a critical tool for identifying various immune disorders, including autoimmune diseases, immunodeficiency conditions, and allergies. By determining the levels and types of immunoglobulins, healthcare providers can gain valuable insights into a patient's immune system status, aiding in accurate diagnosis and personalized treatment planning. DNA Labs UAE, known for its state-of-the-art facilities and expert medical staff, ensures precise and reliable results, making the Immunotyping Serum Test a valuable resource for patients seeking comprehensive understanding and management of their immune health.
The "NRAS Mutation Codon 12, 13, and 61 Test" is a specialized genetic test offered by DNA Labs UAE, aimed at detecting mutations in specific codons (12, 13, and 61) of the NRAS gene. These mutations are significant because they can play a crucial role in the development and progression of various types of cancer, including melanoma, colorectal cancer, and certain types of leukemia. Identifying mutations in these codons can help in diagnosing these cancers, predicting patient outcomes, and determining the most effective treatment strategies, including targeted therapies.
The test involves analyzing the patient's DNA to look for abnormalities in the NRAS gene that may drive cancer growth. It is particularly useful for oncologists and healthcare professionals in personalizing cancer treatment plans, as NRAS mutations can influence how a patient responds to certain medications.
At DNA Labs UAE, the cost for this comprehensive genetic test is set at 1450 AED. The process is conducted in a state-of-the-art laboratory setting, ensuring high accuracy and reliability of the results. Patients considering this test are usually referred by their healthcare providers, and the results can play a critical role in the management of their condition.
The "Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4 Immune Deficiency Panel 4 Markers Test" is a comprehensive diagnostic procedure offered by DNA Labs UAE, priced at 1450 AED. This advanced testing method combines the precision of Real-Time PCR (Polymerase Chain Reaction) technology with an immune deficiency panel to accurately quantify the RNA levels of the Human Immunodeficiency Virus type 1 (HIV-1) in a patient's blood. Additionally, it evaluates the patient's immune system status by analyzing the CD3 and CD4 markers, which are crucial for assessing the strength and functionality of the immune response. This test is pivotal for early detection, monitoring of infection progression, and guiding effective treatment strategies for individuals living with HIV. By providing a detailed insight into both the viral load and the immune system's condition, healthcare providers can tailor more effective and personalized treatment plans.
Beta Thalassemia is a blood disorder that reduces the production of hemoglobin, an iron-containing protein in red blood cells that carries oxygen to cells throughout the body. Individuals with thalassemia may develop anemia, leading to fatigue and other serious health problems. Given the genetic nature of this condition, prenatal screening is crucial for expecting parents, especially those with a family history of the disease or who are carriers of the thalassemia trait.
The Beta Thalassemia Screening Prenatal Test is a vital procedure offered at DNA Labs UAE, designed to detect the risk of the fetus inheriting beta thalassemia. This test is particularly recommended for couples at increased risk, providing them with essential information on their baby's health and allowing for early intervention if needed.
The test involves collecting a small sample of the mother's blood, which is then analyzed for the presence of mutations associated with beta thalassemia. It is a non-invasive procedure that poses no risk to the fetus.
The cost of the Beta Thalassemia Screening Prenatal Test at DNA Labs UAE is 1450 AED. This investment in prenatal health can offer peace of mind to expecting parents and help in the planning and management of potential health issues related to beta thalassemia. Early detection through this screening can be crucial in ensuring the well-being of both the mother and the child.
The "Chromosomes 13 and 21 Test" is a specialized genetic screening conducted at DNA Labs UAE, designed to identify any abnormalities in chromosomes 13 and 21. These chromosomes are significant as their anomalies are linked to certain genetic disorders. For example, trisomy 13, also known as Patau syndrome, is associated with chromosome 13, while trisomy 21 leads to Down syndrome, related to chromosome 21. The test is crucial for early detection, allowing for better preparation and management of potential health issues associated with these chromosomal abnormalities.
DNA Labs UAE offers this testing service for a cost of 1200 AED. The lab utilizes advanced genetic testing technologies to ensure accurate and reliable results. This test is particularly recommended for expectant parents or individuals with a family history of genetic disorders. By opting for this test, one can gain valuable insights into their genetic health or that of their unborn child, facilitating informed medical and personal decisions.
The "Chromosomes 18 X and Y Test" is a specialized genetic analysis offered by DNA Labs UAE, designed to examine the chromosomes associated with determining sex (X and Y) as well as abnormalities related to chromosome 18. This test is crucial for diagnosing various genetic disorders, including but not limited to, Edwards syndrome (trisomy 18), Turner syndrome, Klinefelter syndrome, and other related conditions that can impact physical and mental development.
Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves collecting a sample of the individual's DNA through non-invasive methods, such as a blood draw or cheek swab. The laboratory then uses advanced genetic sequencing technologies to analyze the chromosomes in detail, identifying any anomalies or variations that could indicate a genetic disorder.
The cost of the "Chromosomes 18 X and Y Test" at DNA Labs UAE is set at 1200 AED. This price includes the full process of sample collection, analysis, and a comprehensive report of the findings. The report not only outlines the results but also provides insights and recommendations for further action if any abnormalities are detected. This test is a valuable tool for individuals seeking to understand their genetic health, especially for prospective parents concerned about inherited genetic conditions.
Cord blood, the blood that remains in the umbilical cord and placenta post-delivery, is a rich source of stem cells and genetic material. It is increasingly being utilized for karyotyping tests, which are critical in identifying chromosomal abnormalities in newborns. These tests can detect a wide range of genetic disorders and conditions, such as Down syndrome, Turner syndrome, and Klinefelter syndrome, among others. Conducting a karyotyping test on cord blood offers a non-invasive method to obtain valuable genetic information about the newborn shortly after birth.
At DNA Labs UAE, a leading facility in genetic testing, the karyotyping test using cord blood is available for 1200 AED. This test provides parents and healthcare professionals with essential insights into the baby's genetic health, enabling early intervention and management of potential genetic conditions. The cost of the test includes the collection of cord blood at the time of birth, processing, and detailed analysis by expert geneticists. DNA Labs UAE is equipped with state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of test results, making it a trusted choice for genetic testing services in the region.
The "Cystic Fibrosis Mutation Screening CFTR - Del 508 Test" is a specialized genetic test conducted to identify the presence of the most common mutation, ΔF508 (delta F508), in the CFTR gene associated with cystic fibrosis (CF). This mutation leads to the production of a defective protein that affects the movement of salt and water in and out of cells, resulting in thick, sticky mucus in the lungs, digestive tract, and other areas of the body. Cystic fibrosis is a hereditary disorder characterized by severe damage to the respiratory and digestive systems.
The test involves analyzing a small sample of blood or saliva to check for the ΔF508 mutation. It is crucial for early diagnosis, allowing for timely intervention and management of the disease. This test is particularly recommended for individuals with a family history of cystic fibrosis or partners of people with cystic fibrosis who are considering starting a family.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test cost is set at 1200 AED. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable test results, providing essential information for affected individuals and their families to manage the condition effectively.
